Andrea De Micheli
PhD
Zürich Switzerland
University Children's Hospital Zürich

About
Postdocoral Fellow, Neurooncology
University Children’s Hospital Zurich
Expertise
Neuro-oncology

University Children's Hospital Zürich
Zürich, Switzerland
research
Interests

High-Grade Glioma
High-grade Gliomas (HGG) or astrocytomas in children nearly always result in a dismal prognosis. Although novel therapeutic approaches are currently in development, preclinical testing has been limited, due to a lack of pediatric-specific HGG preclinical models. These models are needed to help test
348
63

Low-Grade Glioma
Low-Grade Gliomas also called astrocytomas are the most common cancer of the central nervous system in children. They represent a heterogeneous group of tumors that can be discovered anywhere within the brain or spinal cord. Although surgical resection may be curative, up to 20% of children still su
1003
23